This inventor holds 1 USPTO granted patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 1997.
Company Filing History:
Years Active: 1997
Title: The Innovations of Ping Ling
Introduction
Ping Ling is a notable inventor based in Nutley, NJ (US). He has made significant contributions to the field of biotechnology, particularly in the study of interleukin-12. His work has implications for understanding immune responses and developing therapeutic strategies.
Latest Patents
Ping Ling holds a patent for the P-40 homodimer of interleukin-12. This patent details the analysis of culture media from p40-transfected COS cells, revealing the presence of 40 kDa monomers and 80 kDa disulfide-linked homodimers. The research indicates that only the homodimer binds to the IL-12 receptor, demonstrating its potential role in immune modulation.
Career Highlights
He is currently employed at Hoffmann-La Roche Inc., where he continues to advance his research in immunology. His findings regarding the inhibition of IL-12-induced proliferation by the 80 kDa dimer have been particularly noteworthy. This research highlights the complex interactions of the IL-12 subunits and their biological activities.
Collaborations
Throughout his career, Ping Ling has collaborated with esteemed colleagues such as Maurice Kent Gately and John Hakimi. These partnerships have fostered a collaborative environment that enhances the research output and innovation in their field.
Conclusion
Ping Ling's contributions to the understanding of interleukin-12 and his innovative patent work underscore his importance in the field of biotechnology. His research continues to pave the way for advancements in immunological therapies.